SCHEMBL131930

SCHEMBL131930

CC(O)C(N1CCN(C(C(C)O)S(=O)(=O)O)CC1)S(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL955956 0.98
Water SCHEMBL421187 0.98
SCHEMBL28214258 0.86 CHRM2 (0.36)
SCHEMBL1234084 0.86 USP2 (0.36)
SCHEMBL443924 0.84 CHRM2 (0.44)
SCHEMBL62393 0.72 KDM4E (0.32)
SCHEMBL6542902 0.70
Water SCHEMBL28800260 0.68 KDM4E (0.30)
SCHEMBL19066410 0.67 LMNA (0.33)
SCHEMBL987341 0.67 SIGMAR1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1600 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026101351-A1 METHOD FOR PREPARING LIPID NANOPARTICLES 주식회사 테르나테라퓨틱스 2026-05-15 WO claimed
US-12582670-B2 Lignin solvation using aqueous biologically compatible buffers UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2026-03-24 US claimed
US-20260077016-A1 NOVEL COMPOSITION COMPRISING ANTIBODIES ARECOR LTD (GB) 2026-03-19 US claimed
US-20260047995-A1 COSMETIC COMPOSITION OF STABILIZED RETINOID BY PH BUFFER MARY KAY INC (US) 2026-02-19 US claimed
US-12491207-B2 Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability VANELTIX PHARMA, INC. (US) 2025-12-09 US claimed
US-20250312297-A1 REDUCTION OF HEALTHCARE RESOURCE UTILIZATION BY PATIENTS TREATED WITH INTRANASALLY-ADMINISTERED METOCLOPRAMIDE EVOKE PHARMA, INC. 2025-10-09 US claimed
US-20250302777-A1 METHODS FOR TREATING GASTROPARESIS EVOKE PHARMA, INC. 2025-10-02 US claimed
US-20250241981-A1 NOVEL COMPOSITION ARECOR LIMITED (GB) 2025-07-31 US claimed
US-20250228803-A1 NASAL FORMULATIONS OF METOCLOPRAMIDE EVOKE PHARMA, INC. 2025-07-17 US claimed
WO-2025064521-A1 ULTRAFILTRATION / DIAFILTRATION PURIFICATION METHODS PROFOUNDBIO US CO. (US) 2025-03-27 WO claimed
WO-2001036000-A1 TEMPERATURE-CONTROLLED AND PH-DEPENDANT SELF-GELLING BIOPOLYMERIC AQUEOUS SOLUTION BIO SYNTECH CANADA, INC. (CA) 2001-05-25 WO claimed
EP-0997504-A1 Inks for ink-jet printers Hewlett-Packard Company (US) 2000-05-03 EP claimed
US-5804403-A MEASURING ETHANOL IN A SAMPLE CONTAINING ALCOHOL DEHYDROGENASE, PYRAZOLE, NAD, SODIUM HYDROXYMETHYLGLCYINATE AND ZWITTERIONIC BUFFER BOEHRINGER MANNHEIM CORPORATION (US) 1998-09-08 US claimed
US-5589327-A Method and composition for the determination of red blood cell floate DADE INTERNATIONAL INC. (US) 1996-12-31 US claimed
US-5563644-A Ink jet printing processes with microwave drying XEROX CORPORATION (US) 1996-10-08 US claimed
EP-0733215-A1 METHODS AND COMPOSITIONS FOR THE DETERMINATION OF RED BLOOD CELL FOLATE DADE INTERNATIONAL INC. (US) 1996-09-25 EP claimed
WO-1996002842-A1 METHODS AND COMPOSITIONS FOR THE DETERMINATION OF RED BLOOD CELL FOLATE DADE INTERNATIONAL INC. (US) 1996-02-01 WO claimed
EP-0559324-B1 Ink jet printing processes with microwave drying XEROX CORP (US) 1995-10-18 EP claimed
US-5354442-A Matrix modification in the electrophoretic separation of nucleic acids THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE COMMERCE (US) 1994-10-11 US claimed
EP-0559324-A1 Ink jet printing processes with microwave drying XEROX CORPORATION (US) 1993-09-08 EP claimed